Alnylam Competitors and Similar CompaniesClear all

Celyad's competitors and similar companies include Sorrento Therapeutics and CureVac.
Celyad
Celyad
Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.
Sorrento Therapeutics
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
CureVac
CureVac
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
Founding Date
Founding Date
2007
Founding Date
2006
Founding Date
2000
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Mont-Saint-Guibert, BE HQ
New York, US
Locations
San Diego, US HQ
San Diego, US
Locations
Tübingen, DE HQ
Ottignies Louvain La Neuve, BE
Wiesbaden, DE
Amsterdam, NL
Basel, CH
Boston, US
Employees
Employees
17
Employees
31019% decrease
Employees
999
Valuation ($)
Valuation ($)
11.8 m
Valuation ($)
1.5 m
Valuation ($)
648.3 m

Financial

Revenue (est.)
Revenue (est.)
€102k (FY, 2023)
Revenue (est.)
$62.8m (FY, 2022)
Revenue (est.)
€53.8m (FY, 2023)
Cost of goods
Cost of goods
€69k (FY, 2023)
Cost of goods
N/A
Cost of goods
€64.3m (FY, 2023)
Gross profit
Gross profit
€1.4m (FY, 2023)
Gross profit
N/A
Gross profit
(€2.6m) (FY, 2023)
Net income
Net income
(€8.4m) (FY, 2023)
Net income
($577.8m) (FY, 2022)
Net income
(€260.2m) (FY, 2023)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 42.6m
Total funding raised
$ 1.1b
For sources of this data, please see the company profile

View Company Profiles

Sorrento Therapeutics
HQ
San Diego, US
Employees
310↓ 19% decrease

Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.

View company
CureVac
HQ
Tübingen, DE
Employees
999

CureVac is a biotechnology company offering messenger RNA (mRNA) technology.

View company